Avid Bioservices Inc (CDMO)

[Couch]

Mentioning PPHM in the same sentence with the immunotherapy drugs from the other three companies is off-base, IMO. When I saw that, I knew I didn’t have to read further.

Yet the opinion of why PPHM should not be mentioned alongside these BP's is not offered up and no flip side solid DD or even a speculative rebuttal on the company is offered additionally......and further implied, is that to read the article further is not warranted. Sounds like bad scientific research protocol. I forget what the term is for this flawed methodology related to conducting scientific research outcome. I'm sorry to say my research days are long behind me.

I'm obviously new and haven't been around for 14 years let alone 14 weeks.....the PPHM learning curve is also obviously more than steep for newbies such as myself. I did, however, read the article in question and found it a nice place to start regarding company DD if I am not mistaken???

For those of us less in the flow of the history of the uphill battle having been waged by the company to get to Phase III....please share why IYO PPHM should not have been mentioned with Bristol Myers, Merck, and Roche? Phase III alone may say otherwise....but I certainly could be missing something more pertinent to the more trained eye so to speak.

Thanks,
Couch